10-Q · 2026-11-09
Bioforce Nanosciences Holdings files Q3 report, highlighting ongoing revenue challenges in the laboratory analytical instruments sector.
| Name | BIOFORCE NANOSCIENCES HOLDINGS, INC. |
|---|---|
| CIK | 0001310488 |
| Tickers | BFNH |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 3826 Laboratory Analytical Instruments |
| EIN | 852138858 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | 757-306-6090 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Bioforce Nanosciences Holdings files Q3 report, highlighting ongoing revenue challenges in the laboratory analytical instruments sector.
Bioforce Nanosciences Holdings has obtained an oil and gas lease in Texas, marking a significant operational expansion for the company.
254 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-09 | 10-Q | QTR. REPORT - SEPT. 30, 2026 | 0001091818-26-000156 | 000-51074 | 261535795 | 34 | 8681814 | 1 | 1 | |
| 2026-10-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001091818-26-000150 | 000-51074 | 261446051 | 34 | 2275690 | 1 | 1 |
| 2026-09-04 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001091818-26-000141 | 005-81683 | 261361694 | 34 | 8121 | |||
| 2026-09-04 | 8-K | CURRENT REPORT | 3.02 | 0001091818-26-000140 | 000-51074 | 261361320 | 34 | 179928 | 1 | 1 |
| 2026-09-04 | 3 | PRIMARY DOCUMENT | 0001091818-26-000139 | 4186 | ||||||
| 2026-09-03 | 3 | PRIMARY DOCUMENT | 0001091818-26-000135 | 3969 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0001091818-26-000134 | 7649 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0001091818-26-000133 | 8428 | ||||||
| 2026-08-18 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001091818-26-000128 | 000-51074 | 261289790 | 34 | 9598973 | 1 | 1 |
| 2026-08-14 | 8-K | CURRENT REPORT | 8.01 | 0001091818-26-000124 | 000-51074 | 261280442 | 34 | 190018 | 1 | 1 |
| 2026-08-10 | 10-Q | QTR. REPORT - JUNE 30, 2026 | 0001091818-26-000108 | 000-51074 | 261259287 | 34 | 10533962 | 1 | 1 | |
| 2026-07-07 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001091818-26-000089 | 000-51074 | 261158699 | 34 | 25921013 | 1 | 1 |
| 2026-07-01 | 8-K | CURRENT REPOT | 8.01,9.01 | 0001091818-26-000087 | 000-51074 | 261142945 | 34 | 2004257 | 1 | 1 |
| 2026-06-18 | 8-K | CURRENT REPORT | 5.01,5.02,8.01,9.01 | 0001091818-26-000084 | 000-51074 | 261100503 | 34 | 959778 | 1 | 1 |
| 2026-05-19 | 10-Q | QTR. REPORT - MARCH 31, 2026 | 0001091818-26-000077 | 000-51074 | 26997001 | 34 | 1618025 | 1 | 1 | |
| 2026-05-13 | NT 10-Q | NOTIFICATION OF LATE FILING | 0001091818-26-000070 | 000-51074 | 26971311 | 34 | 22675 | |||
| 2026-04-15 | 10-K | YEAR- END REPORT - DEC. 31, 2025 | 0001091818-26-000047 | 000-51074 | 26863872 | 34 | 2414461 | 1 | 1 | |
| 2026-03-31 | NT 10-K | NOTIFICATION OF LATE FILING | 0001091818-26-000032 | 000-51074 | 26817166 | 34 | 22582 | |||
| 2025-11-19 | 10-Q | QTR. REPORT - SEPTEMBER 30, 2025 | 0001091818-25-000163 | 000-51074 | 251498050 | 34 | 1671686 | 1 | 1 | |
| 2025-11-13 | NT 10-Q | NOTIFICATION OF LATE FILING | 0001091818-25-000154 | 000-51074 | 251477772 | 34 | 22687 | |||
| 2025-08-11 | 10-Q | QTR. REPORT - JUNE 30, 2025 | 0001091818-25-000091 | 000-51074 | 251201014 | 34 | 1602494 | 1 | 1 | |
| 2025-05-13 | 10-Q | QTR. REPORT - MARCH 31, 2025 | 0001091818-25-000053 | 000-51074 | 25937271 | 34 | 1510824 | 1 | 1 | |
| 2025-04-08 | 10-K | YEAR END REPORT - DEC. 31, 2024 | 0001091818-25-000036 | 000-51074 | 25821790 | 34 | 2331574 | 1 | 1 | |
| 2025-03-28 | NT 10-K | NOTIFICATION OF LATE FILING | 0001091818-25-000030 | 000-51074 | 25786788 | 34 | 23119 | |||
| 2024-11-08 | 10-Q | QTR. REPORT - SEPT. 2024 | 0001091818-24-000134 | 000-51074 | 241438812 | 34 | 1687146 | 1 | 1 | |
| 2024-08-07 | 10-Q | QTR. REPORT - JUNE 30, 2024 | 0001091818-24-000085 | 000-51074 | 241182373 | 34 | 1467833 | 1 | 1 | |
| 2024-05-07 | 8-K | CURRENT REPORT | 4.01,9.01 | 0001091818-24-000056 | 000-51074 | 24922354 | 34 | 188566 | 1 | 1 |
| 2024-05-03 | 10-Q | QTR. REPORT MARCH 31, 2024 | 0001091818-24-000049 | 000-51074 | 24911104 | 34 | 1403531 | 1 | 1 | |
| 2024-04-01 | 10-K | YEAR- END REPORT - DEC. 31, 2023 | 0001091818-24-000034 | 000-51074 | 24808767 | 34 | 2296557 | 1 | 1 | |
| 2023-11-03 | 10-Q | FORM 10Q - SEPT. 30, 2023 | 0001091818-23-000181 | 000-51074 | 231374732 | 34 | 1550963 | 1 | 1 | |
| 2023-10-18 | 4 | PRIMARY DOCUMENT | 0001091818-23-000179 | 8053 | ||||||
| 2023-10-18 | 4 | PRIMARY DOCUMENT | 0001091818-23-000178 | 5028 | ||||||
| 2023-08-01 | 10-Q | QTR. REPORT - JUNE 30, 2023 | 0001091818-23-000146 | 000-51074 | 231131261 | 34 | 1505116 | 1 | 1 | |
| 2023-05-09 | 10-Q | QTR. REPORT - MARCH 31, 2023 | 0001091818-23-000071 | 000-51074 | 23901543 | 34 | 1403527 | 1 | 1 | |
| 2023-03-28 | 10-K | YEAR-END REPORT - DEC. 31, 2022 | 0001091818-23-000044 | 000-51074 | 23767647 | 34 | 2198295 | 1 | 1 | |
| 2022-12-14 | 4 | PRIMARY DOCUMENT | 0001091818-22-000176 | 5807 | ||||||
| 2022-11-02 | 10-Q | QTR. REPORT - SEPTEMBER 30, 2022 | 0001091818-22-000145 | 000-51074 | 221352854 | 34 | 1478962 | 1 | 1 | |
| 2022-10-03 | 4 | PRIMARY DOCUMENT | 0001091818-22-000142 | 5809 | ||||||
| 2022-07-27 | 10-Q | QTR. REPORT - JUNE 30, 2022 | 0001091818-22-000097 | 000-51074 | 221109984 | 34 | 1440401 | 1 | 1 | |
| 2022-05-05 | 10-Q/A | AMENDED QTR REPORT MARCH 31, 2022 | 0001091818-22-000045 | 000-51074 | 22895544 | 34 | 1319386 | 1 | 1 | |
| 2022-05-05 | 10-Q | bfnh-20220331.htm | 0001091818-22-000041 | 000-51074 | 22895226 | 34 | 1318575 | 1 | 1 | |
| 2022-02-11 | 10-K | bfnh10k1221.htm | 0001091818-22-000014 | 000-51074 | 22620150 | 34 | 2170579 | 1 | 1 | |
| 2021-11-30 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001091818-21-000150 | 000-51074 | 211459862 | 34 | 154027 | 1 | 1 |
| 2021-10-28 | 10-Q | QUARTERLY REPORT | 0001091818-21-000138 | 000-51074 | 211356713 | 34 | 1602842 | 1 | 1 | |
| 2021-07-30 | 10-Q/A | AMENDMENT NO. 1 TO QUARTERLY REPORT | 0001091818-21-000101 | 000-51074 | 211133756 | 34 | 1674016 | 1 | 1 | |
| 2021-07-29 | 10-Q | QUARTERLY REPORT | 0001091818-21-000099 | 000-51074 | 211126692 | 34 | 1600305 | 1 | 1 | |
| 2021-06-02 | 8-K | CURRENT REPORT | 8.01 | 0001091818-21-000073 | 000-51074 | 21988990 | 34 | 10583 | ||
| 2021-04-27 | 10-Q | QTR. REPORT -MARCH 31, 2021 | 0001091818-21-000055 | 000-51074 | 21858293 | 34 | 1034569 | 1 | ||
| 2021-02-16 | 10-K | YEAR END REPORT DEC. 31, 2020 | 0001091818-21-000016 | 000-51074 | 21633148 | 34 | 1374587 | 1 | ||
| 2020-12-09 | 4/A | PRIMARY DOCUMENT | 0001091818-20-000273 | 8335 | ||||||
| 2020-12-09 | 4/A | PRIMARY DOCUMENT | 0001091818-20-000272 | 8191 | ||||||
| 2020-12-09 | 4/A | PRIMARY DOCUMENT | 0001091818-20-000271 | 8242 | ||||||
| 2020-12-07 | 4/A | PRIMARY DOCUMENT | 0001091818-20-000262 | 8137 | ||||||
| 2020-12-07 | 4/A | PRIMARY DOCUMENT | 0001091818-20-000261 | 7999 | ||||||
| 2020-12-07 | 4 | PRIMARY DOCUMENT | 0001091818-20-000260 | 7690 | ||||||
| 2020-12-07 | 4 | PRIMARY DOCUMENT | 0001091818-20-000259 | 7634 | ||||||
| 2020-12-04 | 8-K | CURRENT REPORT | 3.02 | 0001091818-20-000258 | 000-51074 | 201369067 | 34 | 9850 | ||
| 2020-10-23 | 10-Q | QTR. REPORT - SEPT. 30, 2020 | 0001091818-20-000228 | 000-51074 | 201256864 | 34 | 1132387 | 1 | ||
| 2020-10-13 | 8-K | CURRENT REPORT | 8.01 | 0001091818-20-000211 | 000-51074 | 201234695 | 34 | 9892 | ||
| 2020-07-22 | 10-Q | QTR. REPORT - JUNE 30, 2020 | 0001091818-20-000170 | 000-51074 | 201041535 | 34 | 1281328 | 1 | ||
| 2020-07-14 | 8-K | CURRENT REPORT | 8.01 | 0001091818-20-000158 | 000-51074 | 201026617 | 34 | 10617 | ||
| 2020-07-09 | 8-K/A | AMENDED: CHANGED WORD "FORMERLY" WITH "FORMALLY" | 8.01 | 0001091818-20-000152 | 000-51074 | 201019889 | 34 | 9573 | ||
| 2020-07-09 | 8-K | CURRENT REPORT | 8.01 | 0001091818-20-000150 | 000-51074 | 201019847 | 34 | 9100 | ||
| 2020-05-18 | 8-K | CURRENT REPORT | 8.01 | 0001091818-20-000129 | 000-51074 | 20888750 | 34 | 9326 | ||
| 2020-05-04 | 10-Q | QTR. REPORT -MARCH 31, 2020 | 0001091818-20-000107 | 000-51074 | 20843494 | 34 | 1222029 | 1 | ||
| 2020-04-02 | 4 | PRIMARY DOCUMENT | 0001091818-20-000079 | 5464 | ||||||
| 2020-04-02 | 4 | PRIMARY DOCUMENT | 0001091818-20-000078 | 5399 | ||||||
| 2020-04-01 | 8-K | CURRENT REPORT | 3.02 | 0001091818-20-000077 | 000-51074 | 20764764 | 34 | 9508 | ||
| 2020-03-09 | 10-K/A | AMENDED YEAR- END REPORT- DEC.31, 2019 | 0001091818-20-000039 | 000-51074 | 20696602 | 34 | 1449810 | 1 | ||
| 2020-03-04 | 10-K | YEAR - END REPORT-DEC.31, 2019 | 0001091818-20-000036 | 000-51074 | 20685670 | 34 | 1449255 | 1 | ||
| 2019-12-31 | UPLOAD | filename1.pdf | 0000000000-19-016880 | 39706 | ||||||
| 2019-12-31 | DEFR14C | REVISED DEFINITIVE INFORMATION STATEMENT NO. 2 INCLUDES EXHIBITS | 0001091818-19-000353 | 000-51074 | 191318472 | 34 | 91314 | |||
| 2019-12-31 | DEFR14C | REVISED DEFINITIVE INFORMATION STATEMENT | 0001091818-19-000351 | 000-51074 | 191317582 | 34 | 41474 | |||
| 2019-12-31 | DEF 14C | DEFINITIVE INFORMATION STATEMENT | 0001091818-19-000349 | 000-51074 | 191317551 | 34 | 41494 | |||
| 2019-12-27 | CORRESP | filename1.htm | 0001091818-19-000340 | 7982 | ||||||
| 2019-12-27 | PRER14C | REVISED PRELIMINARY INFO. STATEMENT | 0001091818-19-000339 | 000-51074 | 191312732 | 34 | 91295 | |||
| 2019-12-23 | UPLOAD | filename1.pdf | 0000000000-19-016716 | 42069 | ||||||
| 2019-12-13 | PRE 14C | PRELIMINARY INFORMATION STATEMENT | 0001091818-19-000322 | 000-51074 | 191283867 | 34 | 85590 | |||
| 2019-11-05 | 10-Q | QTR. ENDING SEPT. 30, 2019 | 0001091818-19-000265 | 000-51074 | 191193203 | 34 | 1030748 | 1 | ||
| 2019-07-22 | 10-Q | QTR. ENDING JUNE 30, 2019 | 0001091818-19-000192 | 000-51074 | 19965078 | 34 | 1022889 | 1 | ||
| 2019-04-30 | 10-Q | QTR. MARCH 31, 2019 | 0001091818-19-000131 | 000-51074 | 19779950 | 34 | 884035 | 1 | ||
| 2019-03-29 | 10-K | YEAR END REPORT- DECEMBER 31, 2018 | 0001091818-19-000088 | 000-51074 | 19713250 | 34 | 1418173 | 1 | ||
| 2018-10-24 | 10-Q | QTR. REPORT-SEPT. 30, 2018 | 0001091818-18-000190 | 000-51074 | 181136425 | 34 | 877478 | 1 | ||
| 2018-08-10 | 3 | PRIMARY DOCUMENT | 0001091818-18-000157 | 4033 | ||||||
| 2018-08-10 | 3 | PRIMARY DOCUMENT | 0001091818-18-000156 | 3882 | ||||||
| 2018-08-10 | 3 | PRIMARY DOCUMENT | 0001091818-18-000155 | 4778 | ||||||
| 2018-08-01 | UPLOAD | filename1.pdf | 0000000000-18-023819 | 35844 | ||||||
| 2018-07-27 | 10-12G/A | AMENDED REGISTRATION STATEMENT | 0001091818-18-000152 | 000-51074 | 18973924 | 34 | 677736 | |||
| 2018-07-24 | 10-Q | QTR. REPORT_JUNE 30, 2018 | 0001091818-18-000150 | 000-51074 | 18966366 | 34 | 169060 | |||
| 2018-06-28 | CORRESP | filename1.htm | 0001091818-18-000132 | 686905 | ||||||
| 2018-06-28 | 10-12G/A | AMENDED REGISTRATION STATEMENT | 0001091818-18-000131 | 000-51074 | 18924302 | 34 | 678390 | |||
| 2018-06-19 | UPLOAD | filename1.pdf | 0000000000-18-018764 | 77606 | ||||||
| 2018-05-25 | CORRESP | filename1.htm | 0001091818-18-000112 | 697505 | ||||||
| 2018-05-25 | 10-12G/A | AMENDED REGISTRATION STATEMENT | 0001091818-18-000111 | 000-51074 | 18861439 | 34 | 677422 | |||
| 2018-05-16 | UPLOAD | filename1.pdf | 0000000000-18-015139 | 175553 | ||||||
| 2018-05-11 | 10-Q | QTR. REPORT- MARCH 31, 2018 | 0001091818-18-000096 | 000-51074 | 18827461 | 34 | 160725 | |||
| 2018-04-25 | CORRESP | filename1.htm | 0001091818-18-000084 | 730325 | ||||||
| 2018-04-25 | 10-12G/A | AMENDED REGISTRATION STATEMENT | 0001091818-18-000083 | 000-51074 | 18774245 | 34 | 699415 | |||
| 2018-04-13 | 10-K | YEAR END REPORT- DECEMBER 31, 2017 | 0001091818-18-000078 | 000-51074 | 18754059 | 34 | 553018 | |||
| 2018-03-29 | NT 10-K | NOTIFICATION OF LATE FILING | 0001091818-18-000062 | 000-51074 | 18723178 | 34 | 22531 | |||
| 2018-03-15 | UPLOAD | filename1.pdf | 0000000000-18-008070 | 189511 | ||||||
| 2018-02-28 | CORRESP | filename1.htm | 0001091818-18-000030 | 698440 | ||||||
| 2018-02-28 | 10-12G/A | AMENDED REGISTRATION STATEMENT | 0001091818-18-000029 | 000-51074 | 18649174 | 34 | 678729 | |||
| 2018-02-13 | UPLOAD | filename1.pdf | 0000000000-18-005012 | 235361 | ||||||
| 2018-01-26 | CORRESP | filename1.htm | 0001091818-18-000014 | 729541 | ||||||
| 2018-01-26 | 10-12G/A | AMENDED REGISTRATION | 0001091818-18-000013 | 000-51074 | 18550562 | 34 | 4156703 | |||
| 2018-01-12 | UPLOAD | filename1.pdf | 0000000000-18-001283 | 187313 | ||||||
| 2017-12-19 | 10-12G | REGISTRATION STATEMENT | 0001091818-17-000250 | 000-51074 | 171263913 | 34 | 2336574 | |||
| 2017-03-02 | 8-K | CURRENT REPORT | 8.01 | 0001091818-17-000029 | 000-51074 | 17657754 | 34 | 7663 | ||
| 2009-04-14 | 15-12G | NOTICE OF TERMINATION OF REGISTRATION | 0001091818-09-000112 | 000-51074 | 09748957 | 34 | 7246 | |||
| 2009-03-31 | NT 10-K | NOTIFICATION OF LATE FILING | 0001091818-09-000103 | 000-51074 | 09719810 | 34 | 23713 | |||
| 2009-03-17 | 8-K | CURRENT REPORT | 1.01,2.04,9.01 | 0001091818-09-000078 | 000-51074 | 09688667 | 34 | 33069 | ||
| 2009-03-17 | 4 | PRIMARY DOCUMENT | 0001091818-09-000076 | 11873 | ||||||
| 2009-03-17 | 4 | PRIMARY DOCUMENT | 0001091818-09-000075 | 11850 | ||||||
| 2009-03-17 | 4 | PRIMARY DOCUMENT | 0001091818-09-000074 | 11858 | ||||||
| 2009-02-06 | 8-K | CURRENT REPORT | 2.04,9.01 | 0001091818-09-000041 | 000-51074 | 09578016 | 34 | 16315 | ||
| 2009-01-16 | 4 | PRIMARY DOCUMENT | 0001091818-09-000021 | 7723 | ||||||
| 2009-01-16 | 4 | PRIMARY DOCUMENT | 0001091818-09-000020 | 7738 | ||||||
| 2009-01-16 | 4 | PRIMARY DOCUMENT | 0001091818-09-000019 | 7716 | ||||||
| 2009-01-15 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001091818-09-000014 | 000-51074 | 09528329 | 34 | 4588061 | ||
| 2008-12-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000387 | 7730 | ||||||
| 2008-12-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000386 | 7739 | ||||||
| 2008-12-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000385 | 7739 | ||||||
| 2008-11-24 | 4 | PRIMARY DOCUMENT | 0001091818-08-000378 | 12424 | ||||||
| 2008-11-21 | 4 | PRIMARY DOCUMENT | 0001091818-08-000375 | 12439 | ||||||
| 2008-11-21 | 4 | PRIMARY DOCUMENT | 0001091818-08-000374 | 12522 | ||||||
| 2008-11-21 | 4 | PRIMARY DOCUMENT | 0001091818-08-000373 | 7994 | ||||||
| 2008-11-21 | 4 | PRIMARY DOCUMENT | 0001091818-08-000372 | 10299 | ||||||
| 2008-11-21 | 4 | PRIMARY DOCUMENT | 0001091818-08-000371 | 7924 | ||||||
| 2008-11-20 | 8-K | CURRENT REPORT | 1.01,3.02,5.01,9.01 | 0001091818-08-000362 | 000-51074 | 081203141 | 34 | 313814 | ||
| 2008-11-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000350 | 5643 | ||||||
| 2008-11-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000349 | 5636 | ||||||
| 2008-11-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000348 | 5649 | ||||||
| 2008-11-14 | 10-Q | QUARTERLY REPORT | 0001091818-08-000337 | 000-51074 | 081189014 | 34 | 348297 | |||
| 2008-11-12 | 8-K | CURRENT REPORT | 5.02,9.01 | 0001091818-08-000330 | 000-51074 | 081178165 | 34 | 26731 | ||
| 2008-10-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000322 | 5648 | ||||||
| 2008-10-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000321 | 5652 | ||||||
| 2008-10-17 | 4 | PRIMARY DOCUMENT | 0001091818-08-000320 | 5638 | ||||||
| 2008-09-23 | 4 | PRIMARY DOCUMENT | 0001091818-08-000290 | 5592 | ||||||
| 2008-09-23 | 4 | PRIMARY DOCUMENT | 0001091818-08-000289 | 5651 | ||||||
| 2008-09-23 | 4 | PRIMARY DOCUMENT | 0001091818-08-000288 | 5645 | ||||||
| 2008-09-19 | 424B3 | PROSPECTUS | 0001091818-08-000285 | 333-146427 | 081079731 | 33 | 351089 | |||
| 2008-09-18 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001091818-08-000266,2008-09-18 | 9999999995-08-002865 | 333-146427 | 081079331 | 33 | 2227 | ||
| 2008-09-09 | POS AM | POST EFFECTIVE AMENDMENT | 0001091818-08-000266 | 333-146427 | 081062972 | 33 | 390839 | |||
| 2008-08-29 | UPLOAD | filename1.pdf | 0000000000-08-043623 | 41561 | ||||||
| 2008-08-29 | 10-Q/A | AMENDED QTR. REPORT | 0001091818-08-000258 | 000-51074 | 081047128 | 34 | 38612 | |||
| 2008-08-28 | 10QSB/A | AMENDED QTR. REPORT | 0001091818-08-000256 | 000-51074 | 081045892 | 34 | 38833 | |||
| 2008-08-27 | 10KSB/A | AMENDED YEAR END FILING | 0001091818-08-000252 | 000-51074 | 081041971 | 34 | 1298773 | |||
| 2008-08-26 | CORRESP | filename1.htm | 0001091818-08-000250 | 92613 | ||||||
| 2008-08-14 | 10-Q | QUARTERLY REPORT | 0001091818-08-000220 | 000-51074 | 081019650 | 34 | 279047 | |||
| 2008-08-13 | 8-K | CURRENT REPORT | 1.01,5.02,9.01 | 0001091818-08-000213 | 000-51074 | 081013062 | 34 | 174747 | ||
| 2008-07-24 | 8-K | CURRENT REPORT | 1.01,3.02,9.01 | 0001091818-08-000193 | 000-51074 | 08967191 | 34 | 324716 | ||
| 2008-07-23 | SC 13D/A | e604038_sc13da-sgamai.txt | 0001193805-08-001750 | 005-81683 | 08964931 | 34 | 15592 | |||
| 2008-07-23 | 4 | xslF345X03/e604037_ex.xml | 0001193805-08-001749 | 7994 | ||||||
| 2008-07-22 | UPLOAD | filename1.pdf | 0000000000-08-036491 | 88103 | ||||||
| 2008-07-16 | 4 | xslF345X03/e604028_ex.xml | 0001193805-08-001731 | 5511 | ||||||
| 2008-07-11 | POS AM | e604022_posam-bioforce.txt | 0001193805-08-001724 | 333-146427 | 08948925 | 33 | 376588 | |||
| 2008-06-20 | SC 13D/A | e603968_sc13da-sgamai.txt | 0001193805-08-001598 | 005-81683 | 08909949 | 34 | 16518 | |||
| 2008-06-20 | SC 13D/A | e603965_sc13da-henderson.txt | 0001193805-08-001591 | 005-81683 | 08908895 | 34 | 15680 | |||
| 2008-06-16 | 8-K | e603957_8k-bioforce.txt | 1.01,3.02,9.01 | 0001193805-08-001574 | 000-51074 | 08899748 | 34 | 209390 | ||
| 2008-06-12 | 4 | xslF345X02/e603948_ex.xml | 0001193805-08-001559 | 7713 | ||||||
| 2008-06-12 | 4 | FORM 4 | 0001193805-08-001557 | 8018 | ||||||
| 2008-06-12 | 4 | xslF345X02/e603950_ex.xml | 0001193805-08-001555 | 7642 | ||||||
| 2008-06-12 | 4 | xslF345X02/e603949_ex.xml | 0001193805-08-001553 | 7638 | ||||||
| 2008-05-15 | 10QSB | e603825_10qsb-bioforce.htm | 0001193805-08-001350 | 000-51074 | 08834424 | 34 | 855623 | |||
| 2008-04-14 | DEF 14A | e603660_def14a-bioscience.htm | 0001193805-08-001098 | 000-51074 | 08753584 | 34 | 468675 | |||
| 2008-03-31 | 10KSB | e603584_10ksb-bioforce.htm | 0001193805-08-000969 | 000-51074 | 08723065 | 34 | 1447939 | |||
| 2008-02-04 | 8-K | FORM 8-K | 7.01,9.01 | 0001193805-08-000184 | 000-51074 | 08571406 | 34 | 2172731 | ||
| 2008-01-25 | 8-K | FORM 8-K | 5.02,8.01,9.01 | 0001193805-08-000143 | 000-51074 | 08549277 | 34 | 10798 | ||
| 2007-11-21 | 8-K | e602883_8k-bioforce.txt | 2.02,8.01,9.01 | 0001193805-07-002954 | 000-51074 | 071262588 | 34 | 22799 | ||
| 2007-11-14 | 10QSB | e602834_10qsb-bioforce.htm | 0001193805-07-002884 | 000-51074 | 071246513 | 34 | 1492135 | |||
| 2007-10-15 | 424B3 | FORM 424B3 | 0001193805-07-002615 | 333-146427 | 071170963 | 33 | 356876 | |||
| 2007-10-12 | EFFECT | xslEFFECTX01/primary_doc.xml | SB-2,,2007-10-12 16:00:00 | 9999999995-07-004044 | 333-146427 | 071170858 | 33 | 2215 | ||
| 2007-10-12 | SB-2/A | e602704_sb2a-bnh.txt | 0001193805-07-002611 | 333-146427 | 071169660 | 33 | 398583 | |||
| 2007-10-03 | 3 | FORM 3 | 0001193805-07-002521 | 7745 | ||||||
| 2007-10-01 | SB-2 | FORM SB-2 | 0001193805-07-002504 | 333-146427 | 071146840 | 33 | 408600 | |||
| 2007-09-07 | 8-K | e602595_8k-bioforce.txt | 1.01,3.02,5.03,9.01 | 0001193805-07-002379 | 000-51074 | 071107049 | 34 | 859123 | ||
| 2007-08-14 | 10QSB | e602444_10qsb-bioforce.txt | 0001193805-07-002054 | 000-51074 | 071051493 | 34 | 206293 | |||
| 2007-08-10 | 8-K | e602447_8k-bioforce.txt | 2.02,9.01 | 0001193805-07-002037 | 000-51074 | 071044826 | 34 | 23532 | ||
| 2007-06-27 | 8-K | LIVE FILING | 7.01,9.01 | 0001299933-07-003861 | 000-51074 | 07942625 | 34 | 17853 | ||
| 2007-06-19 | 8-K | LIVE FILING | 5.02,8.01,9.01 | 0001299933-07-003728 | 000-51074 | 07928497 | 34 | 17779 | ||
| 2007-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-07-037276 | 5935 | ||||||
| 2007-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-07-037275 | 5983 | ||||||
| 2007-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-07-037271 | 6007 | ||||||
| 2007-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-07-037270 | 5917 | ||||||
| 2007-06-15 | 3/A | FORM 3/A SUBMISSION | 0001209191-07-037267 | 5131 | ||||||
| 2007-06-15 | 3/A | FORM 3/A SUBMISSION | 0001209191-07-037263 | 10341 | ||||||
| 2007-06-15 | 3/A | FORM 3/A SUBMISSION | 0001209191-07-037260 | 6503 | ||||||
| 2007-06-15 | 3/A | FORM 3/A SUBMISSION | 0001209191-07-037257 | 6485 | ||||||
| 2007-05-25 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001193805-07-001400 | 000-51074 | 07880539 | 34 | 2976397 | ||
| 2007-05-15 | 10QSB | FORM 10-QSB | 0001193805-07-001309 | 000-51074 | 07849376 | 34 | 82105 | |||
| 2007-05-14 | 8-K | CURRENT REPORT | 2.02,9.01 | 0001193805-07-001296 | 000-51074 | 07846926 | 34 | 22618 | ||
| 2007-04-03 | UPLOAD | filename1.pdf | 0000000000-07-016501 | 15556 | ||||||
| 2007-04-02 | 10KSB | FORM 10-KSB | 0001193805-07-000928 | 000-51074 | 07735142 | 34 | 721895 | |||
| 2007-03-23 | SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 0001193805-07-000860 | 005-81683 | 07713174 | 34 | 15891 | |||
| 2007-03-14 | CORRESP | filename1.txt | 0000931731-07-000025 | 10440 | ||||||
| 2007-03-14 | 8-K/A | BIOFORCE 8KA 031307 | 4.02 | 0000931731-07-000024 | 000-51074 | 07693541 | 34 | 7214 | ||
| 2007-03-09 | 8-K | CURRENT REPORT | 7.01,9.01 | 0001193805-07-000748 | 000-51074 | 07683397 | 34 | 22334418 | ||
| 2007-02-05 | 4 | xslF345X02/form4-frey04112006_ex.xml | 0000931731-07-000016 | 5798 | ||||||
| 2007-02-05 | 3 | xslF345X02/form3-frey_ex.xml | 0000931731-07-000015 | 7900 | ||||||
| 2007-02-05 | 3/A | xslF345X02/form3a-lgold022406_ex.xml | 0000931731-07-000014 | 9459 | ||||||
| 2007-02-05 | 3/A | xslF345X02/form3a-jjsunier_ex.xml | 0000931731-07-000013 | 9474 | ||||||
| 2007-02-05 | 4 | xslF345X02/form4-ehenderson113006_ex.xml | 0000931731-07-000012 | 6160 | ||||||
| 2007-02-05 | 3/A | FORM 3A - EHENDERSON 022406 | 0000931731-07-000011 | 11591 | ||||||
| 2007-01-29 | UPLOAD | filename1.pdf | 0000000000-07-004492 | 25764 | ||||||
| 2007-01-24 | 3 | xslF345X02/form3-brown_ex.xml | 0000931731-07-000004 | 7944 | ||||||
| 2007-01-16 | 8-K | BIOF 8-K 011607 | 5.02,7.01 | 0000931731-07-000002 | 000-51074 | 07532695 | 34 | 19071 | ||
| 2006-11-17 | 10QSB | BIOF 10QSB 093006 | 0000931731-06-000252 | 000-51074 | 061227060 | 34 | 62632 | |||
| 2006-11-17 | 10QSB/A | BIOF 10QSBA 093006 | 0000931731-06-000251 | 000-51074 | 061227058 | 34 | 64361 | |||
| 2006-11-15 | NT 10-Q | BIOF NT 10Q 093006 | 0000931731-06-000248 | 000-51074 | 061219116 | 34 | 7422 | |||
| 2006-11-14 | 8-K/A | BIOF 8KA 111306 | 9.01 | 0000931731-06-000238 | 000-51074 | 061210952 | 34 | 69322 | ||
| 2006-11-13 | CORRESP | filename1.txt | 0000931731-06-000239 | 6240 | ||||||
| 2006-11-09 | 10QSB/A | BIOF 10QSB-A 033106 | 0000931731-06-000234 | 000-51074 | 061201997 | 34 | 59394 | |||
| 2006-10-27 | CORRESP | filename1.txt | 0000931731-06-000228 | 4051 | ||||||
| 2006-10-06 | 8-K | BIOFORCE 8K 100506 | 5.02,9.01 | 0000931731-06-000215 | 000-51074 | 061132188 | 34 | 9143 | ||
| 2006-09-26 | 8-K | BIOFORCE 8K 092606 | 7.01,9.01 | 0000931731-06-000207 | 000-51074 | 061109550 | 34 | 14071 | ||
| 2006-09-14 | UPLOAD | filename1.pdf | 0000000000-06-044345 | 28352 | ||||||
| 2006-08-11 | 10QSB | BIOFORCE 10QSB 063006 | 0000931731-06-000159 | 000-51074 | 061025688 | 34 | 120666 | |||
| 2006-08-07 | 10QSB/A | BIOFORCE 10QSBA 033106 | 0000931731-06-000153 | 000-51074 | 061010050 | 34 | 315292 | |||
| 2006-08-07 | 8-K | BIOFORCE 8K 080706 XCPA | 4.01,9.01 | 0000931731-06-000152 | 000-51074 | 061009572 | 34 | 9082 | ||
| 2006-08-07 | 8-K | BIOFORCE 8K 080706 | 4.01,9.01 | 0000931731-06-000151 | 000-51074 | 061009437 | 34 | 10175 | ||
| 2006-08-07 | 8-K/A | BIOFORCE 8K AMENDED 080706 | 9.01 | 0000931731-06-000150 | 000-51074 | 061009418 | 34 | 68668 | ||
| 2006-07-12 | UPLOAD | filename1.pdf | 0000000000-06-032333 | 35215 | ||||||
| 2006-05-22 | 10QSB | BIOFORCE 10QSB 033106 | 0000931731-06-000112 | 000-51074 | 06857501 | 34 | 55013 | |||
| 2006-05-16 | NT 10-Q | BIOFORCE-NT10Q - 033106 | 0000931731-06-000105 | 000-51074 | 06844878 | 34 | 7795 | |||
| 2006-04-17 | 10KSB | BIOFORCE 10KSB 123105 | 0000931731-06-000083 | 000-51074 | 06762835 | 34 | 188128 | |||
| 2006-04-03 | NT 10-K | BIOFORCE NT 10K 123105 | 0000931731-06-000071 | 000-51074 | 06732642 | 34 | 8087 | |||
| 2006-03-20 | SC 13D | SC 13D - EHENDERSON | 0000931731-06-000051 | 005-81683 | 06697898 | 34 | 137292 | |||
| 2006-03-20 | SC 13D | SC 13D - SGAMAI | 0000931731-06-000050 | 005-81683 | 06697897 | 34 | 138696 | |||
| 2006-03-13 | 3 | FORM 3 - LGOLD 022406 | 0000931731-06-000046 | 9375 | ||||||
| 2006-03-13 | 3 | FORM 3 - JSUNIER 022406 | 0000931731-06-000045 | 9398 | ||||||
| 2006-03-13 | 3 | FORM 3 - EHENDERSON 022406 | 0000931731-06-000044 | 8760 | ||||||
| 2006-03-13 | 3 | xslF345X02/form3-sgam022406_ex.xml | 0000931731-06-000043 | 7970 | ||||||
| 2006-03-02 | 8-K | BIOFORCE 8K - 030206 | 2.01,9.01 | 0000931731-06-000034 | 000-51074 | 06660137 | 34 | 324501 | ||
| 2006-02-24 | 8-K | BIOFORCE 8K 022406 | 7.01 | 0000931731-06-000033 | 000-51074 | 06643325 | 34 | 6307 | ||
| 2006-01-12 | REGDEX | AUTO-GENERATED PAPER DOCUMENT | 06 | 9999999997-06-004008 | 021-85819 | 06021058 | 34 | 1763 | ||
| 2006-01-10 | DEF 14C | SRVV DEF 14C | 0000931731-06-000002 | 000-51074 | 06522319 | 34 | 350887 | |||
| 2005-12-29 | PRE 14C | SRVV PRE 14C | 0000931731-05-000273 | 000-51074 | 051292133 | 34 | 351197 | |||
| 2005-12-22 | 3 | xslF345X02/form3-rpc_ex.xml | 0000931731-05-000270 | 3963 | ||||||
| 2005-12-22 | 3 | xslF345X02/form3-hnk122205_ex.xml | 0000931731-05-000268 | 3850 | ||||||
| 2005-12-20 | 3 | xslF345X02/form3-hdeworthwms121605_ex.xml | 0000931731-05-000266 | 3889 | ||||||
| 2005-12-19 | 4/A | xslF345X02/form4-efcowle121605_ex.xml | 0000931731-05-000265 | 5062 | ||||||
| 2005-12-16 | 4 | xslF345X02/form4-efcowle121605_ex.xml | 0000931731-05-000264 | 4771 | ||||||
| 2005-12-01 | 8-K | SILVER RIVER 8K 120105 | 1.01,9.01 | 0000931731-05-000256 | 000-51074 | 051238355 | 34 | 119061 | ||
| 2005-11-15 | NT 10-Q | SILVER RIVER NT 10Q 093005 | 0000931731-05-000225 | 000-51074 | 051204159 | 34 | 6969 | |||
| 2005-11-14 | 10QSB | SILVER RIVER 10QSB 093005 | 0000931731-05-000228 | 000-51074 | 051204181 | 34 | 41139 | |||
| 2005-10-24 | 8-K | SILVER RIVER 8K XCPA | 4.01,9.01 | 0000931731-05-000201 | 000-51074 | 051151436 | 34 | 8642 | ||
| 2005-08-12 | 10QSB | SILVER RIVER 10QSB 063005 | 0000931731-05-000147 | 000-51074 | 051018639 | 34 | 48848 | |||
| 2005-05-11 | 10QSB | SILVER RIVER 10QSB 033105 | 0000931731-05-000082 | 000-51074 | 05819408 | 34 | 47788 | |||
| 2005-03-31 | 10KSB | SILVER RIVER 10KSB 123104 | 0000931731-05-000057 | 000-51074 | 05715553 | 34 | 124570 | |||
| 2005-01-19 | CORRESP | filename1.txt | 0000931731-05-000008 | 5939 | ||||||
| 2005-01-19 | 10SB12G/A | SILVER RIVER AMEND #1 | 0000931731-05-000007 | 000-51074 | 05535489 | 34 | 131868 | |||
| 2005-01-05 | UPLOAD | filename1.txt | 0000000000-05-000964 | 5446 | ||||||
| 2004-12-14 | 10SB12G | SILVER RIVER VENTURES 10SB DEC 04 | 0000931731-04-000367 | 000-51074 | 041199732 | 34 | 169886 |
One latest value per concept from companyfacts (80 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 38.07M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 2.63M | 2025-06-30 | 2025 | FY | 10-K | 2026-04-15 | 0001091818-26-000047 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 11,836 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 5,735 | 2018-12-31 | 2019 | FY | 10-K/A | 2020-03-09 | 0001091818-20-000039 | |
| us-gaap | AccruedSalariesCurrentAndNoncurrent | Accrued Salaries | USD | 506,203 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 161.76M | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | Assets | Assets | USD | 786 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 786 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | Cash | Cash | USD | 605 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-22 | 0001091818-20-000170 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 786 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -13,030 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-16 | 0001091818-21-000016 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 31,696 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -10,355 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001091818-22-000145 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 30,910 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 900.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 38.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 38.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 33,522 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | CompensationExpenseExcludingCostOfGoodAndServiceSold | Compensation Expense, Excluding Cost of Good and Service Sold | USD | 283,250 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | ConversionOfStockSharesIssued1 | Conversion of Stock, Shares Issued | shares | 1,167 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-11 | 0001091818-22-000014 |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 13,415 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-16 | 0001091818-21-000016 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 12,555 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K/A | 2020-03-09 | 0001091818-20-000039 |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 30,855 | 2019-12-31 | 2019 | FY | 10-K/A | 2020-03-09 | 0001091818-20-000039 | |
| us-gaap | DueFromBanks | Due from Banks | USD | 39,260 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-22 | 0001091818-20-000170 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 164,681 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001091818-22-000145 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.01 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.02 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-11 | 0001091818-22-000014 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.01 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K/A | 2020-03-09 | 0001091818-20-000039 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 802,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 438,494 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | GrossProfit | Gross Profit | USD | 4,360 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-16 | 0001091818-21-000016 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -721,744 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K/A | 2020-03-09 | 0001091818-20-000039 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 48,180 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -5,735 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-16 | 0001091818-21-000016 |
| us-gaap | IncreaseDecreaseInAccruedSalaries | Increase (Decrease) in Accrued Salaries | USD | 110,500 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 17,500 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 13,255 | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-10-23 | 0001091818-20-000228 |
| us-gaap | Liabilities | Liabilities | USD | 619,329 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 786 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 619,329 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 145,592 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -114,682 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -205,410 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -341,680 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 516,334 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 721,744 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -372,153 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-19 | 0001091818-25-000163 |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 114,200 | 2019-12-31 | 2019 | FY | 10-K/A | 2020-03-09 | 0001091818-20-000039 | |
| us-gaap | OtherExpenses | Other Expenses | USD | 5,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | PaymentsToAcquireBusinessesGross | Payments to Acquire Businesses, Gross | USD | 1,000 | 2020-05-01 | 2020-05-06 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-23 | 0001091818-20-000228 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2021-12-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001091818-22-000041 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 1.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | ProceedsFromContributedCapital | Proceeds from Contributed Capital | USD | 100 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001091818-22-000145 |
| us-gaap | ProceedsFromContributionsFromParent | Proceeds from Contributions from Parent | USD | 100 | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-03 | 0001091818-23-000181 |
| us-gaap | ProceedsFromOtherEquity | Proceeds from Other Equity | USD | 1,339 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-11 | 0001091818-22-000014 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 65,074 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001091818-26-000047 |
| us-gaap | ProceedsFromRepaymentsOfRelatedPartyDebt | Proceeds from (Repayments of) Related Party Debt | USD | 143,592 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -1.17M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-19 | 0001091818-25-000163 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 1,527 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings | Restricted Stock, Shares Issued Net of Shares for Tax Withholdings | shares | 4.25M | 2025-01-02 | 2025-01-24 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001091818-26-000108 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -162.41M | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | Revenues | Revenues | USD | 17,775 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-16 | 0001091818-21-000016 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 158.00M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-10-23 | 0001091818-20-000228 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 0.79 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-11 | 0001091818-22-000014 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -618,543 | 2026-12-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 | |
| us-gaap | StockIssuedDuringPeriodSharesAcquisitions | Stock Issued During Period, Shares, Acquisitions | shares | 100,000 | 2020-05-01 | 2020-05-06 | 2023 | Q3 | 10-Q | 2023-11-03 | 0001091818-23-000181 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 4.25M | 2025-01-02 | 2025-01-24 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 8,075 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-04-15 | 0001091818-26-000047 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeBenefitPlan | Stock Issued During Period, Value, Employee Benefit Plan | USD | 100 | 2022-07-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-03 | 0001091818-23-000181 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 2.17M | 2025-01-02 | 2025-01-24 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 34.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 29.27M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-11 | 0001091818-22-000014 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 34.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001091818-26-000156 |